Sign in

You're signed outSign in or to get full access.

Patrick Gamble

Executive Vice President, Operations at Quipt Home Medical
Executive

About Patrick Gamble

Patrick Gamble is Executive Vice President, Operations at Quipt Home Medical (QIPT), appointed in June 2024; he is 61 and previously led sales and operations at Great Elm Healthcare prior to its acquisition by Quipt in January 2023, and earlier held operational leadership roles at Preferred Homecare . Company operating performance over FY 2023–FY 2024 shows revenue growth from $211.7M to $245.9M and EBITDA growth from $40.1M to $46.0M, indicative of execution progress during the integration period of acquired platforms (see table; values with asterisks from S&P Global) . Quipt’s compensation framework emphasizes base salary, discretionary annual cash bonuses, and equity under the 2024 Equity Incentive Plan (EIP), with a mandatory clawback policy and prohibitions on hedging/pledging that align pay with shareholder outcomes .

Past Roles

OrganizationRoleYearsStrategic impact
Quipt Home MedicalSenior Director of Sales & OperationsJan 2023 – Jun 2024Led sales and operations post-acquisition integration of Great Elm Healthcare .
Great Elm HealthcareRegional Manager → Director of Sales & Operations → Senior DirectorJan 2020 – Jan 2023Led >280 employees across multi-state RT/Complex Rehab/Sleep Lab; organization revenues >$60M; experience scaling multi-site operations prior to acquisition by Quipt (Jan 2023) .
Preferred HomecareArea ManagerMay 2014 – Dec 2019Managed multi-site RT/DME-Complex Rehab operations with area revenues >$75M .

External Roles

  • No public company board roles or external directorships disclosed for Mr. Gamble in the latest DEF 14A .

Fixed Compensation

  • Individual base salary, target bonus %, and actual bonus for Mr. Gamble are not disclosed in the latest proxy; he is not listed as a Named Executive Officer (NEO) . Company-wide constructs include base salary and discretionary bonuses determined by the Compensation Committee .

Performance Compensation

  • Individual incentive plan metrics (weightings/targets/payouts) for Mr. Gamble are not disclosed. Company-wide, the short-term bonus framework is discretionary (financial and other goals), and long-term incentives are granted under the 2024 EIP; no grants were awarded under the 2024 EIP for FY 2024 .

Equity Ownership & Alignment

Common share ownership and transactions

DateSourceDirect common sharesNotes
2024-10-01SEC Form 323,057Initial Section 16 filing on becoming reporting person .
2024-12-26SEC Form 440,057Open market purchases of 17,000 shares at $2.4191 and $2.47 per share; total ~$41,633 .
  • Ownership as % of shares outstanding: 0.093% (40,057 / 43,091,273) using the 43,091,273 shares outstanding at record date Jan 16, 2025 and the 40,057 shares post-purchase .

Option awards (from Form 3)

InstrumentAmountExercise price (USD)ExpirationVested (as of 10/01/2024)UnvestedNotes
Stock Options15,000$6.1402/20/20337,5007,500Exercise price CAD 8.30 converted at 0.74 USD/CAD rate; see vesting schedule below .
  • As of 09/30/2024, Quipt’s closing share price was $2.92 (Nasdaq), implying these options were out-of-the-money at that date .
  • Hedging, shorting, derivatives, margin accounts, and pledging of company securities are prohibited under Quipt’s insider trading policy, reducing alignment risk from monetization strategies .

Option vesting schedule (remaining tranches)

Vesting dateOptions vesting
2024-11-201,250
2025-02-201,250
2025-05-201,250
2025-08-201,250
2025-11-201,250
2026-02-201,250
Source: SEC Form 3 vesting schedule .

Employment Terms

  • No individual employment agreement (term, severance, or change-in-control multiple) is disclosed for Mr. Gamble in the proxy. The proxy describes such agreements only for the CEO and CFO (initial 3-year term from Nov 1, 2020, auto-renewal, and severance constructs), not for other executives .
  • 2024 Equity Incentive Plan: Board discretion to accelerate vesting/settlement of awards in connection with a change in control or termination of service, subject to applicable law and plan terms .
  • Clawback: Adopted in 2023; requires recoupment of erroneously awarded incentive-based compensation upon a financial restatement, without regard to fault, consistent with SEC Rule 10D-1 and Nasdaq rules .
  • Hedging/pledging prohibitions: Policy bans hedging, short sales, options on company securities, margin accounts, and pledging of shares .

Performance & Track Record

Company operating performance during FY 2023–FY 2024

Metric (USD)FY 2023FY 2024
Revenues$211.677M*$245.915M
EBITDA$40.145M $45.990M*
  • Revenue growth FY 2024 vs FY 2023: ~16.2% (derived from values above) .
  • EBITDA growth FY 2024 vs FY 2023: ~14.6% (derived from values above) .
  • Values marked with an asterisk (*) were retrieved from S&P Global.

Context and execution notes:

  • Gamble’s operating background centers on scaling multi-state respiratory/DME and complex rehab operations and integrating acquired platforms (Great Elm), consistent with Quipt’s acquisitive model .
  • His December 2024 open market purchase (17,000 shares) indicates positive alignment in the early phase of his EVP tenure .

Investment Implications

  • Insider alignment and buying: Gamble’s Form 4 showed net open-market buying (17,000 shares) at ~$2.42–$2.47, lifting direct holdings to 40,057 shares; no sales reported in that filing. This is a positive alignment signal and can help reduce perceived near-term selling pressure .
  • Option-related selling pressure appears limited near term: As of 9/30/2024, Quipt’s share price ($2.92) was below Gamble’s $6.14 option strike, indicating options were out-of-the-money, limiting exercise-driven selling incentives at that time .
  • Governance safeguards: A formal clawback and prohibitions on hedging/pledging/margin use enhance alignment and reduce governance red flags for executives including Gamble .
  • Retention risk: No individual employment agreement terms are disclosed for Gamble (severance/CIC protections not specified), though the EIP provides Board discretion to accelerate/adjust equity upon CIC/termination; this creates some ambiguity on retention economics vs. CEO/CFO .
  • Execution and value creation: FY 2023–FY 2024 revenue and EBITDA growth frame an improving operational backdrop as Gamble steps into EVP, Operations; continued integration discipline and organic growth execution remain central to value creation .

Notes and sources:

  • Executive biography and prior roles: DEF 14A (Jan 24, 2025) .
  • Compensation framework, committee composition/governance, hedging/pledging policy, clawback, EIP capacities: DEF 14A .
  • Shares outstanding for ownership %: DEF 14A .
  • Form 3 (initial beneficial ownership and options/vesting): SEC filing (Oct 1, 2024) .
  • Form 4 (Dec 26, 2024 purchases): SEC filing .
  • FY financials: Revenues and EBITDA from S&P Global via GetFinancials; citations as provided above; asterisks denote values retrieved from S&P Global.